EFFECTS OF PROLONGED ADMINISTRATION OF THE 19-NOR-TESTOSTERONE DERIVATIVES NORETHINDRONE AND NORGESTREL TO FEMALE NZB/W MICE - COMPARISON WITH MEDROXYPROGESTERONE AND ETHINYL ESTRADIOL

被引:20
作者
KEISLER, LW [1 ]
KIER, AB [1 ]
WALKER, SE [1 ]
机构
[1] UNIV MISSOURI,DEPT MED,COLUMBIA,MO 65201
关键词
AUTOIMMUNITY; SYSTEMIC LUPUS ERYTHEMATOSUS; ORAL CONTRACEPTIVES; SYNTHETIC PROGESTINS; MEDROXYPROGESTERONE; ETHINYL ESTRADIOL;
D O I
10.3109/08916939108997120
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To evaluate effects of commonly used progestational estrogenic contraceptive steroids in a hormone-responsive model of lupus, we treated female NZB/W mice before clinical disease (6 wks of age) and after onset of lupus (24 wks of age) with doses of hormones titered to suppress reproduction. We report efficacy of norethindrone (NE) and norgestrel (NG), progestins derived from 19-nor-testosterone, in delaying expression of anti-DNA antibodies. Mice implanted with NG at 24 wks of age had prolonged lifespans. In contrast, the hydroxyprogesterone derivative, medroxyprogesterone acetate (MP), did not affect autoimmune disease. These observations suggest that prolonged administration of 19-nor-testosterone derivatives, in small doses adequate to suppress reproduction, may have ameliorative effects in systemic lupus erythematosus. Mice receiving ethinyl estradiol (EE) plus courses of tetracycline to suppress cystitis had active anti-DNA responses. In 60% of EE-treated mice, however, early deaths resulted from malignant lymphomas and complications of obstructive uropathy. Estrogen toxicity, rather than accelerated lupus, was the major cause of death in NZB/W mice treated with EE. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:21 / 32
页数:12
相关论文
共 49 条
[1]  
Dubois E.L., The clinical picture of systemic lupus erythema- tosus, Lupus Erythematosus, pp. 232-242, (1974)
[2]  
Zurier R.B., Systemic lupus erythematosus and pregnancy, Systemic Lupus Erythematosus, pp. 541-554, (1987)
[3]  
Chapel T.A., Burns R.E., Oral contraceptives and exacerbation of lupus erythematosus, Am J Obsret Gynecol, 110, pp. 366-369, (1971)
[4]  
Jungers P., Dougados M., Pelissier C., Kuttenn F., Tron F., Lesavre P., Et al., Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus, Arthritis Rheum, 25, pp. 618-623, (1982)
[5]  
Mintz G., Gutierrez G., Deleze M., Rodriguez E., Contraception with progestagens in systemic lupus erythematosus, Contraception, 30, pp. 29-38, (1984)
[6]  
Howie J.B., Helyer B.J., The immunology and pathology of NZB mice, Adv Immunol, 9, pp. 215-266, (1968)
[7]  
Steinberg A.D., Pincus T., Talal N., DNA-binding assay for detection of anti-DNA antibodies in NZB/NZW F1 mice, J Immunol, 102, pp. 788-790, (1969)
[8]  
Roubinian J.R., Talal N., Greenspan J.S., Goodman J.R., Siiteri P.K., Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice, J Exp Med, 147, pp. 1568-1583, (1978)
[9]  
Roubinian J., Talal N., Siiteri P.K., Sadakian J.A., Sex hormone modulation of autoimmunity in NZB/NZW mice, Arthritis Rheum, 22, pp. 1162-1169, (1979)
[10]  
Verheul H.A.M., Schot L.P.C., Deckers G.H.J., Schuurs A., Effects of tibolone, lynestrenol, ethylestrenol, and desogestrel on autoimmune disorders in NZB/W mice, Clin Immunol Immunopathol, 8, pp. 198-208, (1986)